Robert Strzinek, PhD, DO, leads Protenium Clinical Research with more than 15 years of experience. Following the acquisition, Dr. Strzinek will conduct research at his practice in partnership with the integrated research organization Elligo, providing his patients with access to clinical research as a care option via the Elligo Research Ready network.
Mary Costello, vice president, network management and patient advocacy, Elligo Health Research, said joining Elligo benefits not only patients, but also the Protenium team, by providing them access to technology, tools, and support.
“It is our experience that many community physicians leave research not due to the research itself but to all the administrative, regulatory, and logistical challenges that accompany it,” Costello told Outsourcing-Pharma.
“Elligo and our communities of research seeks to help by providing the expertise and teams physicians need to support their staff and focus on patients and the successful conduct of clinical trials,” she added.
All employees will be kept on, Costello said, with new career opportunities to be available for all of the team members as part of a broader community.
Post acquisition, Elligo’s network now includes more than one million patients.
